
Lupin launches Ophthalmic Suspension for Inflammation in US
Mumbai: Lupin Limited (Lupin) has announced the launch of Loteprednol Etabonate Ophthalmic Suspension, in the United States. The ophthalmic suspension is bioequivalent to Lotemax, marketed by Bausch & Lomb Inc. The drug is indicated for the treatment …